CHELMSFORD, Mass., Nov. 8, 2022 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) and the Authorities of Luxembourg in the present day introduced the signing of a Memorandum of Understanding (“MoU”) to facilitate continued healthcare know-how growth in Luxembourg. The Minister of the Financial system of Luxembourg, Mr. Franz Fayot, and the President and CEO of Azenta, Steve Schwartz, signed the MoU at Azenta’s Massachusetts-based world headquarters. Azenta, Inc. had just lately acquired B Medical Techniques, a number one world vaccine, and medical chilly chain supplier, primarily based in Luxembourg.
The MoU signing ceremony was attended by a number of senior dignitaries from the Ministry of the Financial system of Luxembourg, Ministry of Larger Schooling and Analysis of Luxembourg, Luxembourg Commerce and Funding Workplace in New York, Luxinnovation and Azenta, Inc. Mr. Luc Provost, CEO of B Medical Techniques, and Mr. Jesal Doshi, Deputy CEO of B Medical Techniques, represented B Medical Techniques, a subsidiary of Azenta, through the ceremony.
Confirming Azenta’s need to protect the manufacturing actions of its subsidiary in Luxembourg, B Medical Techniques, and to proceed the initiatives undertaken by the subsidiary till then, the memorandum of understanding confirms the intention of the Ministry of the Financial system to proceed to assist the event of the corporate in Luxembourg. The acquisition by Azenta also needs to give B Medical Techniques entry to new markets, because of the group’s intensive community of shoppers in international locations the place B Medical Techniques has not beforehand had a major presence.
The MoU signing ceremony was adopted by a go to to Azenta’s genomics lab in Waltham, Massachusetts by the delegation of the Ministry of Well being led by the Vice Prime Minister and Minister of Well being, Ms. Paulette Lenert, and the delegation of the Ministry of the Financial system led by the Minister of Financial system, Mr. Franz Fayot.
The Minister of the Financial system Franz Fayot said: “The truth that a world-renowned firm corresponding to Azenta has acquired B Medical Techniques, considered one of our industrial flagships, demonstrates the dynamism of the Luxembourg well being know-how sector, which is among the pillars of Luxembourg’s financial diversification technique. By this memorandum of understanding, our goal is to proceed the great collaboration that already existed with B Medical Techniques, notably in its future analysis, growth and innovation initiatives, in addition to to establish doable synergies.”
“We look ahead to continued partnership and engagement with the Authorities of Luxembourg. B Medical Techniques, which just lately grew to become part of Azenta, has a protracted historical past of operations in Luxembourg, and we intend to construct upon this already sturdy observe file of development and innovation,” mentioned Steve Schwartz, President and CEO of Azenta.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a number one supplier of life sciences options worldwide, enabling impactful breakthroughs and therapies to market quicker. Azenta offers a full suite of dependable cold-chain pattern administration options and genomic providers throughout areas corresponding to drug growth, scientific analysis and superior cell therapies for the business’s prime pharmaceutical, biotech, tutorial and healthcare establishments globally. Azenta just lately acquired B Medical Techniques, a number one world vaccine, and medical chilly chain supplier, primarily based in Luxembourg.
Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For extra data, please go to www.azenta.com.
Head of Investor Relations
SOURCE Azenta, Inc.